Publications of the Week Selective Targeting of PARP-2 Inhibits Androgen Receptor Signaling and Prostate Cancer Growth through Disruption of FOXA1 Function Gui, B., et al. | July 9, 2019 While androgen deprivation therapy (ADT) has been the mainstay of treatment for advanced prostate cancer…sciencecityJuly 9, 2019 Read More